The first line therapy by Teikyo-NKT before chemotherapy to patients with advanced non-small cell lung cancer.
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000027782
- Lead Sponsor
- Teikyo University Chiba Medeical Ceater
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
autoimmune disease HBsAg + HCVAb + HTLV-1Ab + HIVAb + brain meta, carcinomatous pleurisy, carcinomatous peritonitis, carcinomatous meningitis (uncntrollable) serious lung disease (interstitial pneumonia etc) medication of steroid or immunosuppressant multicentric cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility and safety of Teikyo-NKT before chemothaepy to advanced non-small cell lung cancer.
- Secondary Outcome Measures
Name Time Method Efficacy of Teikyo-NKT before chemothaepy to advanced non-small cell lung cancer.